Pre-emption right

ION announces revised record date for Rights Offering for new convertible Second Lien Notes or common stock

Retrieved on: 
Mardi, mars 9, 2021

The original record date of March 15, 2021 has been rescheduled to March 22, 2021 (the Record Date).

Key Points: 
  • The original record date of March 15, 2021 has been rescheduled to March 22, 2021 (the Record Date).
  • Each of our shareholders as of the Record Date will receive one non-transferable subscription right (Right) for each share of our Common Stock they own.
  • We expect to distribute the certificates evidencing the Rights and other materials related to the Rights Offering shortly after the Record Date.
  • To complete the Rights Offering and effect the Restructuring Transactions, we must receive net proceeds of at least $20,000,000 from the Rights Offering.

Biofrontera AG announces the closing of the capital raise with gross proceeds of EUR 24.7 million

Retrieved on: 
Vendredi, février 26, 2021

The capital increase was carried out by way of a subscription rights offering to existing shareholders of Biofrontera AG under German law.

Key Points: 
  • The capital increase was carried out by way of a subscription rights offering to existing shareholders of Biofrontera AG under German law.
  • The Company raised total gross proceeds of approximately EUR 24.7 million.
  • As previously announced, Biofrontera AG has completed a concurrent subscription rights offering of its ordinary shares under German law to its existing shareholders.
  • The Company successfully placed a total of 1,334,002 ADSs (2,668,004 shares) for gross proceeds of USD 8.9 million through the underwriters.

Tiziana Life Sciences plc ("Tiziana" or the "Company") - Tiziana Files Registration Statement on Form F-3 with U.S. Securities and Exchange Commission

Retrieved on: 
Mercredi, janvier 27, 2021

The filing of the Registration Statement with the SEC does not affect the statutory pre-emption rights of shareholders in the Company.

Key Points: 
  • The filing of the Registration Statement with the SEC does not affect the statutory pre-emption rights of shareholders in the Company.
  • The securities registered pursuant to the Registration Statement may not be sold nor may offers to buy be accepted prior to the time the Registration Statement becomes effective.
  • The filing of the Registration Statement does not affect the statutory preemption rights of shareholders in the Company.
  • A copy of the Registration Statement may be obtained on the SEC's website at www.sec.gov.

ENERGISME: Energisme raises €6.07 million in a great successful private placement round.

Retrieved on: 
Mardi, janvier 19, 2021

ENERGISME: Energisme raises 6.07 million in a great successful private placement round.

Key Points: 
  • ENERGISME: Energisme raises 6.07 million in a great successful private placement round.
  • Boulogne-Billancourt, 19 January 2021 - 8.00 a.m. - ENERGISME (FR0013399359/Ticker: ALNRG), a French provider of SaaS technology for energy performance management, today announced the success of its capital increase, without pre-emptive subscription rights, through a private placement with accelerated bookbuilding.
  • The round generated considerable demand from French and European investors, for a total of 14.89 million, i.e.
  • The capital increase was carried out without pre-emptive subscription rights through private placement.

TUI AG: Admission of Subscription Rights settled in the form of Depositary Interests ('DI Pre-Emptive Rights') and notice of intention to cancel trading of DI Pre-Emptive Rights

Retrieved on: 
Lundi, janvier 11, 2021

THIS ANNOUNCEMENT DOES NOT CONSTITUTE A RECOMMENDATION CONCERNING ANY INVESTOR'S DECISION OR OPTIONS WITH RESPECT TO THE OFFERING (AS DEFINED BELOW).

Key Points: 
  • THIS ANNOUNCEMENT DOES NOT CONSTITUTE A RECOMMENDATION CONCERNING ANY INVESTOR'S DECISION OR OPTIONS WITH RESPECT TO THE OFFERING (AS DEFINED BELOW).
  • THE CONTENTS OF THIS ANNOUNCEMENT ARE NOT TO BE CONSTRUED AS LEGAL, BUSINESS, FINANCIAL OR TAX ADVICE.
  • The Company intends to cancel the trading of the DI Pre-Emptive Rights on a multilateral trading facility of the London Stock Exchange (the Cancellation).
  • Therefore, shareholders or investors who take no action will not receive any compensation for any unexercised Subscription Rights or DI Pre-Emptive Rights and will be diluted.

Addex Announces Pricing of $10.0 Million Global Offering

Retrieved on: 
Jeudi, janvier 7, 2021

The aggregate gross proceeds from the offering are expected to be $10.0 million, before deducting the underwriting discounts and commissions and offering expenses payable by Addex.

Key Points: 
  • The aggregate gross proceeds from the offering are expected to be $10.0 million, before deducting the underwriting discounts and commissions and offering expenses payable by Addex.
  • The offering is expected to close on or about January 11, 2021, subject to satisfaction of customary closing conditions.
  • In connection with the offering, Addex has granted the underwriter a 30-day option to purchase up to additional 900,000 shares (or ADSs) at the public offering price, less the underwriting discounts and commissions.
  • The New Shares will be issued from existing authorized share capital of Addex under exclusion of the existing shareholders pre-emptive rights.

Eltek Announces the Terms of Rights Offering

Retrieved on: 
Lundi, novembre 9, 2020

PETACH-TIKVA, Israel, November 9, 2020 /PRNewswire/ --Eltek Ltd. (NASDAQ: ELTK), a global manufacturer and supplier of technologically advanced solutions in the field of printed circuit boards, today provided the key dates and terms of its rights offering.

Key Points: 
  • PETACH-TIKVA, Israel, November 9, 2020 /PRNewswire/ --Eltek Ltd. (NASDAQ: ELTK), a global manufacturer and supplier of technologically advanced solutions in the field of printed circuit boards, today provided the key dates and terms of its rights offering.
  • A registration statement relating to the rights offering has been filed with the U.S. Securities and Exchange Commission ("SEC") and was declared effective today.
  • Under the terms of the rights offering, Eltek is distributing to its holders of ordinary shares as of the record date of November 9, 2020, at no charge, one non-transferable subscription rights for each three ordinary shares held or deemed held on the record date.
  • The estimated net proceeds from the rights offering of approximately $5.6 million, assuming full participation in the rights offering and after deducting expenses related to the rights offering, will be used to repay our existing indebtedness to Nistec (our controlling shareholder), for working capital and other general corporate purposes, including investment in fixed assets.

Xtant Medical Announces Record Date and Other Key Dates for Proposed $15 Million Rights Offering

Retrieved on: 
Jeudi, octobre 22, 2020

Subject to the registration statement relating to the rights offering becoming effective on or about November 3, 2020, the Company intends to commence the offering on November 5, 2020.

Key Points: 
  • Subject to the registration statement relating to the rights offering becoming effective on or about November 3, 2020, the Company intends to commence the offering on November 5, 2020.
  • At the commencement of the rights offering, each holder of common stock will receive 0.194539 non-transferable subscription rights for each share of common stock held on the record date.
  • No fractional shares will be issued in the rights offering.
  • Any fractional shares of common stock created by the exercise of rights will be rounded down to the nearest whole share.

Kahoot! AS: Equity Private Placement to SoftBank

Retrieved on: 
Mardi, octobre 13, 2020

or the "Company") is pleased to announce that it has completed a private placement to a subsidiary of SoftBank Group Corp. ("SoftBank"), through issuance of 43,000,000 new shares, at a price of NOK 46 per share, raising NOK 1,978 million (appr.

Key Points: 
  • or the "Company") is pleased to announce that it has completed a private placement to a subsidiary of SoftBank Group Corp. ("SoftBank"), through issuance of 43,000,000 new shares, at a price of NOK 46 per share, raising NOK 1,978 million (appr.
  • The Private Placement implies a deviation from the existing shareholders' pre-emptive rights to subscribe for and be allocated new shares.
  • Further, the Private Placement involves limited financial dilution to existing shareholders, which the Board considers as justifiable when taking into account the expected contribution of the Private Placement to the long-term success of the Company.
  • The Board is of the view that the Private Placement is in the common interest of the Company and its shareholders.

Ampco-Pittsburgh Corporation Reminds Shareholders of Approaching Rights Offering Expiration

Retrieved on: 
Jeudi, septembre 10, 2020

The rights offering will allow Ampco-Pittsburghs rights holders to purchase up to 12,800,795 units.

Key Points: 
  • The rights offering will allow Ampco-Pittsburghs rights holders to purchase up to 12,800,795 units.
  • The rights offering includes an over-subscription privilege, which entitles each rights holder that exercises all its basic subscription privileges in full the right to purchase additional units that remain unsubscribed at the Expiration Time.
  • If a rights holder does not exercise their subscription rights before the Expiration Time, such rights will be deemed expired and void and will have no value.
  • Such rights holders will then own the same number of the Corporations common shares as before the commencement of the rights offering.